Aziz Mottiwala News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aziz mottiwala. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aziz Mottiwala Today - Breaking & Trending Today

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., May 29, 2024 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting. ....

United States , Jeff Farrow , David Nakasone , Aziz Mottiwala , Bobak Azamian , Adrienne Kemp , Corporate Communications , Tarsus Pharmaceuticals Inc , Chief Financial , Chief Strategy Officer , Chief Commercial Officer , Chief Executive Officer , Tarsus Pharmaceuticals , Meibomian Gland Disease ,

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61.00

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Aziz Mottiwala , Seshadri Neervannan , Financial Services , Proshare Advisors , News Ratings For Tarsus Pharmaceuticals Daily , Tarsus Pharmaceuticals Inc , Tarsus Pharmaceuticals Company Profile , Analyst Recommendations For Tarsus Pharmaceuticals , Goldman Sachs Group , Bleakley Financial Group , Securities Exchange Commission , Lord Abbett , Tarsus Pharmaceuticals Stock Performance , Tarsus Pharmaceuticals , Institutional Trading Of Tarsus Pharmaceuticals , Russell Investments Group Ltd , Jefferies Financial Group , Get Free Report , Financial Group , Exchange Commission , Share Advisors , Investments Group , Thoroughbred Financial Services , Tarsus Pharmaceuticals Daily ,

Vivo Capital LLC Has $36.13 Million Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

Vivo Capital LLC Has $36.13 Million Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Bryan Wahl , Aziz Mottiwala , Zurcher Kantonalbank Zurich Cantonalbank , Tarsus Pharmaceuticals Stock Down , Mirae Asset Global Investments Co , Goldman Sachs Group , Tarsus Pharmaceuticals Inc , News Ratings For Tarsus Pharmaceuticals Daily , Securities Exchange Commission , China Universal Asset Management Co , Jefferies Financial Group , Vivo Capital , Quarter For Tarsus Pharmaceuticals , Raymond James Associates , Ieq Capital , Tarsus Pharmaceuticals , Free Report , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Mirae Asset Global Investments , Pharmaceuticals Stock Down , Get Free Report , General Counsel Bryan Wahl , Exchange Commission , Financial Group ,

abrdn plc Purchases New Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

Abrdn plc acquired a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 72,032 shares of the company’s stock, valued at approximately $1,459,000. abrdn plc owned approximately 0.22% of Tarsus Pharmaceuticals as of […] ....

United States , Bobakr Azamian , Aziz Mottiwala , Zurcher Kantonalbank Zurich Cantonalbank , Tarsus Pharmaceuticals Inc , Tarsus Pharmaceuticals Company Profile , Securities Exchange Commission , Mirae Asset Global Investments Co , Tarsus Pharmaceuticals Stock , Quarter For Tarsus Pharmaceuticals , News Ratings For Tarsus Pharmaceuticals Daily , Raymond James Associates , Tarsus Pharmaceuticals , Goldman Sachs Group , Ieq Capital , Exchange Commission , Jefferies Financial Group , China Universal Asset Management Co , Free Report , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Mirae Asset Global Investments , Get Free Report , Financial Group , Tarsus Pharmaceuticals Daily , Nasdaq Tars ,

abrdn plc Buys New Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)

Abrdn plc purchased a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 72,032 shares of the company’s stock, valued at approximately $1,459,000. Several other hedge funds have also recently made changes to their positions in TARS. RTW Investments LP boosted its position […] ....

United States , Aziz Mottiwala , Bryan Wahl , Allspring Global Investments Holdings , Jefferies Financial Group , Goldman Sachs Group , Tarsus Pharmaceuticals , Tarsus Pharmaceuticals Company Profile , Tarsus Pharmaceuticals Inc , Insider Activity At Tarsus Pharmaceuticals , Vanguard Group Inc , Deerfield Management Companylp Series , Quarter For Tarsus Pharmaceuticals , News Ratings For Tarsus Pharmaceuticals Daily , Tarsus Pharmaceuticals Stock , Artisan Partners Limited Partnership , Free Report , Partners Limited Partnership , Global Investments Holdings , Financial Group , General Counsel Bryan Wahl , Get Free Report , Visit Holdingschannel , Tarsus Pharmaceuticals Daily , Nasdaq Tars , Sec Filings ,